JPH01121205A - Skin beautifying cosmetic - Google Patents
Skin beautifying cosmeticInfo
- Publication number
- JPH01121205A JPH01121205A JP62280059A JP28005987A JPH01121205A JP H01121205 A JPH01121205 A JP H01121205A JP 62280059 A JP62280059 A JP 62280059A JP 28005987 A JP28005987 A JP 28005987A JP H01121205 A JPH01121205 A JP H01121205A
- Authority
- JP
- Japan
- Prior art keywords
- cosmetic
- kojic acid
- acid
- aloe
- skin beautifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 37
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims abstract description 30
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229960004705 kojic acid Drugs 0.000 claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 18
- 230000002087 whitening effect Effects 0.000 claims description 27
- 229940069521 aloe extract Drugs 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 abstract description 15
- -1 pack Substances 0.000 abstract description 15
- 239000006210 lotion Substances 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 12
- 235000011399 aloe vera Nutrition 0.000 abstract description 9
- 241001116389 Aloe Species 0.000 abstract description 8
- 239000006071 cream Substances 0.000 abstract description 5
- 239000007788 liquid Substances 0.000 abstract description 3
- 238000013329 compounding Methods 0.000 abstract 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000004615 ingredient Substances 0.000 description 14
- 235000019441 ethanol Nutrition 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000003205 fragrance Substances 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 210000002752 melanocyte Anatomy 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000003906 humectant Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 241000589220 Acetobacter Species 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 244000062730 Melissa officinalis Species 0.000 description 2
- 235000010654 Melissa officinalis Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000228143 Penicillium Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229940067596 butylparaben Drugs 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- CSUUDNFYSFENAE-UHFFFAOYSA-N (2-methoxyphenyl)-phenylmethanone Chemical compound COC1=CC=CC=C1C(=O)C1=CC=CC=C1 CSUUDNFYSFENAE-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- HMFKFHLTUCJZJO-UHFFFAOYSA-N 2-{2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy}ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCC(OCCO)C1OCC(OCCO)C1OCCO HMFKFHLTUCJZJO-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- YVIGPQSYEAOLAD-UHFFFAOYSA-L disodium;dodecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOP([O-])([O-])=O YVIGPQSYEAOLAD-UHFFFAOYSA-L 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- WYVGZXIHGGQSQN-UHFFFAOYSA-N hexadecanoate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCCCCC(O)=O WYVGZXIHGGQSQN-UHFFFAOYSA-N 0.000 description 1
- NHOGTCIENBDOGA-UHFFFAOYSA-N hexadecanoic acid;potassium Chemical compound [K].CCCCCCCCCCCCCCCC(O)=O NHOGTCIENBDOGA-UHFFFAOYSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960002163 hydrogen peroxide Drugs 0.000 description 1
- DLINORNFHVEIFE-UHFFFAOYSA-N hydrogen peroxide;zinc Chemical compound [Zn].OO DLINORNFHVEIFE-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 229960004995 magnesium peroxide Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 244000242985 soap aloe Species 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080236 sodium cetyl sulfate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- TVMQDNRQQWQICK-UHFFFAOYSA-M sodium;6-(hydroxymethyl)-4-oxopyran-3-olate Chemical compound [Na+].OCC1=CC(=O)C([O-])=CO1 TVMQDNRQQWQICK-UHFFFAOYSA-M 0.000 description 1
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229940105296 zinc peroxide Drugs 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は美白効果に優れた化粧料に関するものである。[Detailed description of the invention] [Industrial application field] The present invention relates to cosmetics with excellent whitening effects.
更に詳しくは、コウジ酸及び/又はその誘導体とアロエ
抽出液及び/又は抽出粉末を化粧料基剤に配合し、美白
効果を改善せしめた美白化粧料に関するものである。More specifically, the present invention relates to a whitening cosmetic composition in which kojic acid and/or its derivatives and aloe extract and/or extract powder are blended into a cosmetic base to improve the whitening effect.
皮膚美白効果を有する化粧料は消費者、特に20代後半
以降の熟年女性には関心が極めて高く、特に、皮膚上に
現われるシミの防止及びシミ斑点の除去を安全で且つ効
果的に達成し得るものが従来から要望されている。その
ため、多くの研究者らによって、シミ発生に関与すると
考えられるチロシナーゼ酵素の活性抑制及び活性メラノ
サイトの消失等を指標に、美白成分の探索及び種々の美
白化粧料が研究開発又は提供されている。Cosmetics that have a skin whitening effect are of great interest to consumers, especially middle-aged women in their late 20s and above, and in particular can safely and effectively prevent age spots that appear on the skin and remove age spots. Things have been traditionally requested. Therefore, many researchers are searching for whitening ingredients and researching, developing, or providing various whitening cosmetics based on the inhibition of the activity of tyrosinase enzyme and the disappearance of active melanocytes, which are thought to be involved in the generation of age spots.
美白化粧料を得るために、以前は過酸化水素、過酸化亜
鉛、過酸化マ゛グネシウム等の過酸化物、アスコルビン
酸、グルタチオン、コロイド硫黄や各種天然物が美白成
分として配合されてきた。しかし、過酸化物やアスコル
ビン酸は安定性、保存性等に問題があり、またその効果
も充分なものとは言い難い。一方、グルタチオンやコロ
イド硫黄は異臭を有するため化粧料への配合には難点が
あった・
更に、米国などではハイドロキノンを皮膚脱色剤として
使用しているが、このものは美白効果はあるものの安全
性(刺激性、アレルギー性)の面から化粧料に配合する
ことには問題がある。In order to obtain whitening cosmetics, peroxides such as hydrogen peroxide, zinc peroxide, and magnesium peroxide, ascorbic acid, glutathione, colloidal sulfur, and various natural products have previously been blended as whitening ingredients. However, peroxides and ascorbic acid have problems in stability, storage stability, etc., and their effects cannot be said to be sufficient. On the other hand, glutathione and colloidal sulfur have a strange odor, which makes it difficult to incorporate them into cosmetics.Furthermore, in the United States and other countries, hydroquinone is used as a skin bleaching agent, but although it has a whitening effect, it is not safe. There are problems with incorporating it into cosmetics from the viewpoint of (irritation and allergy).
従って、最近では上記の如き問題のない皮膚美白効果を
有する種々の美白成分又は化粧料が鋭意開発されている
。例えば、アスペルギルス属、ペニシリウム属、アセト
バクター属等から生産されるコウジ酸及びコウジ酸誘導
体を用いた美白化粧料が提案されている(特公昭56−
18569号、特開昭53−3538号、特公昭61−
60801号、特公昭5g−22151号、特公昭60
−9722号)。また、クエルセチン及び/又はその誘
導体を有効成分とする化粧料(特開昭55−92305
号、特開昭58−131911号)、カテキン等を有効
成分とする化粧料(特開昭52−44375号)等も開
発されているが、実際の使用に際しては、それら美白成
分の安定性が未だ不十分であったり、また細胞レベルで
は効果が認められるものの、動物、ヒトではその効果が
充分に発揮できない等の種々の問題が残されているのが
現状である。Therefore, in recent years, various whitening ingredients or cosmetics that have skin whitening effects without the above-mentioned problems have been intensively developed. For example, whitening cosmetics using kojic acid and kojic acid derivatives produced from the genus Aspergillus, Penicillium, Acetobacter, etc. have been proposed (Japanese Patent Publication No. 1973-
No. 18569, JP-A No. 53-3538, JP-A No. 61-
No. 60801, Special Publication No. 5g-22151, Special Publication No. 1986
-9722). In addition, cosmetics containing quercetin and/or its derivatives as an active ingredient (Japanese Patent Application Laid-Open No. 55-92305
Cosmetics containing catechins as active ingredients (Japanese Patent Application Laid-Open No. 52-44375) have also been developed, but the stability of these whitening ingredients is difficult to find in actual use. At present, various problems remain, such as that it is still insufficient, and that although it is effective at the cellular level, it is not fully effective in animals and humans.
本発明は前記の問題を解決し、美白効果に優れた化粧料
を提供することを目的とする。The present invention aims to solve the above-mentioned problems and provide a cosmetic with excellent whitening effects.
更に詳しくは、本発明は、美白成分として知られている
コウジ酸及び/又はその誘導体の美白効果をより改善さ
せる併用物質を配合した化粧料を提供することを目的と
する。More specifically, the present invention aims to provide a cosmetic containing a concomitant substance that further improves the whitening effect of kojic acid and/or its derivatives, which are known as whitening ingredients.
本発明者らは、シミの形態及び生理学的性状を検討した
ところ、シミ部位は正常部位に比べ水分が低下し、皮膚
硬化しているとの知見が得られた。The present inventors investigated the morphology and physiological properties of age spots and found that the age of age spots has lower moisture content than normal areas, and the skin is hardened.
そこで、その皮膚状態の改善を目的に、各種の抗炎症剤
、創傷治癒剤、保湿剤とコウジ酸及び/又はその誘導体
との併用効果を検討した結果、コウジ酸及び/又はその
誘導体とアロエ抽出液及び/又は抽出粉末を化粧料に併
用配合することにより、美白効果をより改善できること
を見いだした。本発明はかかる知見に基づいて完成され
たものである。Therefore, with the aim of improving the skin condition, we investigated the effects of combining various anti-inflammatory agents, wound healing agents, and moisturizers with kojic acid and/or its derivatives, and found that kojic acid and/or its derivatives and aloe extract It has been found that the whitening effect can be further improved by combining the liquid and/or extracted powder with cosmetics. The present invention was completed based on this knowledge.
即ち、本発明は、コウジ酸及び/又はその誘導体とアロ
エ抽出液及び/又は抽出粉末を含有することを特徴とす
る美白化粧料を提供するものである。That is, the present invention provides a whitening cosmetic material containing kojic acid and/or a derivative thereof and an aloe extract and/or extract powder.
本発明に使用されるコウジ酸は、化学名が5−ヒドロキ
シ−2−ヒドロキシメチル−4−ピロンであり、アスペ
ルギルス属、ペニシリウム属、アセトバクター属などの
微生物から生産される発酵抽出液やその再結晶等による
精製品、あるいは合成的手法などにより得られた合成品
が使用できる。コウジ酸及びその塩は市販されており容
易に入手できる。The chemical name of the kojic acid used in the present invention is 5-hydroxy-2-hydroxymethyl-4-pyrone, and it can be used in fermentation extracts produced from microorganisms such as Aspergillus, Penicillium, and Acetobacter. Purified products such as crystals or synthetic products obtained by synthetic methods can be used. Kojic acid and its salts are commercially available and can be easily obtained.
本発明におけるコウジ酸の誘導体は、コウジ酸の5−及
び/又は2−ヒドロキシ基の反応誘導体が含まれる。こ
のような誘導体としては、炭素数3〜22の脂肪酸エス
テル、炭素数3〜22の脂肪族エーテル、ポリオキシア
ルキレン(炭素数2〜3)誘導体等を好ましいものとし
て挙げることができる。The derivatives of kojic acid in the present invention include reaction derivatives of 5- and/or 2-hydroxy groups of kojic acid. Preferred examples of such derivatives include fatty acid esters having 3 to 22 carbon atoms, aliphatic ethers having 3 to 22 carbon atoms, and polyoxyalkylene (having 2 to 3 carbon atoms) derivatives.
本発明で使用されるアロエ抽出液及び/又は抽出粉末は
、アロエベラ、シャボンアロエ、キダチアロエ等の全草
又は東部もしくは東部より葉部を除いたゼリ一部から圧
搾、破砕、粉砕等の製造方法で得られるもの、また、更
に、変色しやすい有色成分の除去のために行なわれる活
性炭処理等による精製品及び分画品も使用できる。The aloe extract and/or extracted powder used in the present invention can be produced by pressing, crushing, crushing, etc. from the whole plant or the eastern part of Aloe vera, soap aloe, Kidachi aloe, etc. What is obtained can also be used, as well as purified products and fractionated products obtained by treatment with activated carbon to remove colored components that are prone to discoloration.
本発明においては、前述のコウジ酸及び/又はその誘導
体とアロエ抽出液及び/又は抽出粉末の両者を含有せし
めることが必須であり、どちらか一方のみを含有した化
粧料では本発明の目的である美白効果の改善は達成でき
ない。In the present invention, it is essential to contain both the above-mentioned kojic acid and/or its derivatives and aloe extract and/or extract powder, and cosmetics containing only either one of them are the objects of the present invention. Improvement in whitening effect cannot be achieved.
本発明の効果については、アロエ抽出液及び/又は抽出
粉末の創傷治癒作用、細胞賦活作用、保湿作用によって
、前述のごとく、表皮及び真皮に異常(水分の低下及び
皮膚硬化)を起こしているシミの部位が改善され、沈着
したメラニンを排除しやすくしたためと、また、更には
、皮膚状態が改善されたことにより美白剤であるコウジ
酸成分の角質層への移行をスムーズにし、経皮吸収性を
高めたためと考えられる。As for the effects of the present invention, the wound healing, cell activation, and moisturizing effects of the aloe extract and/or extract powder can be applied to stains that have abnormalities in the epidermis and dermis (reduction in water content and skin hardening), as described above. This is because the area has been improved, making it easier to remove deposited melanin, and furthermore, because the skin condition has been improved, the skin whitening agent kojic acid component can be smoothly transferred to the stratum corneum, and transdermal absorption has been improved. This is thought to be due to the increase in
本発明の美白化粧料には、例えば、クリーム、乳液、化
粧水、パック剤、パウダー、リップクリーム、口紅、ア
ンダーメークアップ、ファンデーション、サンケア等多
くのものが包含される。The whitening cosmetics of the present invention include, for example, creams, emulsions, lotions, packs, powders, lip balms, lipsticks, under-make-up, foundations, sun care, and many others.
前記コウジ酸及び/又はその誘導体(以下、コウジ酸成
分とも言う)と、アロエ抽出液及び/又は抽出粉末(以
下、アロエ成分とも言う)の化粧料への配合量は、剤型
に応じて任意に選択されるが、通常は、該化粧料中にコ
ウジ酸成分が0.01〜10重量2、アロエ成分が0.
01〜15重量〆になるように配合することが好ましい
。各成分の配合量が0.01重量%未満では本発明の好
ましい効果が得られない。上限については特に制限はな
いが多量に配合した場合、製品の安定性及びベトッキ等
の使用感が劣るため、化粧料としては好ましくなく、そ
の配合量の上限は、コウジ酸成分の場合10重量%及び
アロエ成分の場合15重量ぶにするのが好ましい。また
、各成分の配合の方法は、従来の生理活性成分等を配合
する方法に準じて行なうことができる。The amounts of the kojic acid and/or its derivatives (hereinafter also referred to as kojic acid component) and aloe extract and/or extract powder (hereinafter also referred to as aloe component) in the cosmetic may be determined according to the dosage form. Usually, the amount of kojic acid component in the cosmetic is 0.01 to 10% by weight, and the amount of aloe component is 0.01 to 10% by weight2.
It is preferable to mix so that the weight limit is 0.01 to 15. If the amount of each component is less than 0.01% by weight, the desired effects of the present invention cannot be obtained. There is no particular upper limit on the upper limit, but if a large amount is blended, the stability of the product and the feeling of use such as stickiness will be poor, so it is not preferred as a cosmetic.The upper limit of the blended amount is 10% by weight in the case of kojic acid component. In the case of aloe components, it is preferable to use 15% by weight. Moreover, the method of blending each component can be carried out in accordance with the conventional method of blending physiologically active ingredients and the like.
本発明の化粧料には、前述成分の他に、通常化粧料に用
いられる添加成分1例えば、界面活性剤、油脂類、アル
コール類、保湿剤、増粘剤、防腐剤、酸化防止剤、キレ
ート剤、phi整剤、香料、色素、紫外線吸収・散乱剤
、水等を配合可能である。これらの添加成分具体例を示
すと、例えば、界面活性剤としては、親油型グリセリン
モノステアレート、自己乳化型グリセリンモノステアレ
ート、ポリグリセリンモノステアレート、ソルビタンモ
ノオレート、ポリエチレングリコールモノステアレート
、ポリオキシエチレンソルビタンモノオレート、ポリオ
キシエチレンセチルエーテル、ポリオキシエチレン化ス
テロール、ポリオキシエチレン化ラノリン、ポリオキシ
エチレン化ミツロウ、ポリオキシエチレン硬化ヒマシ油
等のノニオン界面活性剤;ステアリン酸ナトリウム、パ
ルミチン酸カリウム、セチル硫酸ナトリウム、ラウリル
リン酸ナトリウム、パルミチン酸トリエタノールアミン
、ポリオキシエチレンラウリルリン酸ナトリウム、N−
アシルグルタミン酸ナトリウム等のアニオン界面活性剤
;塩化ステアリルジメチルベンジルアンモニウム、塩化
ステアリルトリメチルアンモニウム等のカチオン界面活
性剤;塩酸アルキルアミノエチルグリシン液、レシチン
等の両性界面活性剤等を例示することができる。In addition to the above-mentioned ingredients, the cosmetic of the present invention contains additive ingredients normally used in cosmetics, such as surfactants, oils and fats, alcohols, humectants, thickeners, preservatives, antioxidants, and chelates. It is possible to incorporate agents, phi adjusters, fragrances, pigments, ultraviolet absorbing/scattering agents, water, etc. Specific examples of these additive components include, for example, as surfactants, lipophilic glycerin monostearate, self-emulsifying glycerin monostearate, polyglycerin monostearate, sorbitan monooleate, polyethylene glycol monostearate, Nonionic surfactants such as polyoxyethylene sorbitan monooleate, polyoxyethylene cetyl ether, polyoxyethylene sterol, polyoxyethylene lanolin, polyoxyethylene beeswax, polyoxyethylene hydrogenated castor oil; sodium stearate, palmitic acid Potassium, sodium cetyl sulfate, sodium lauryl phosphate, triethanolamine palmitate, polyoxyethylene sodium lauryl phosphate, N-
Examples include anionic surfactants such as sodium acylglutamate; cationic surfactants such as stearyldimethylbenzylammonium chloride and stearyltrimethylammonium chloride; and amphoteric surfactants such as alkylaminoethylglycine hydrochloride and lecithin.
油脂類としては、ヒマシ油、オリーブ油、カカオ脂、椿
油、ヤシ油、木ロウ、ホホバ油、グレープシード油、ア
ボガド油等の植物油脂類;ミンク油、卵黄油等の動物油
脂類;ミツロウ、鯨ロウ。Examples of oils and fats include vegetable oils such as castor oil, olive oil, cacao butter, camellia oil, coconut oil, wood wax, jojoba oil, grapeseed oil, and avocado oil; animal oils and fats such as mink oil and egg yolk oil; beeswax, and whale oil. Row.
ラノリン、カルナウバロウ、キャンデリラロウ等のロウ
類:流動パラフィン、スクワラン、マイクロクリスタリ
ンワックス、セレシンワックス、パラフィンワックス、
ワセリン等の炭化水素類;ラウリン酸、ミリスチン酸、
ステアリン酸、オレイン酸、イソステアリン酸、ベヘニ
ン酸等の天然及び合成脂肪酸類;セタノール、ステアリ
ルアルコール、ヘキシルデカノール
ル、ラウリルアルコール等の天然及び合成高級アルコー
ル類;ミリスチン酸イソプロピル、パルミチン酸イソプ
ロピル、ミリスチン酸オクチルドデシル、オレイン酸オ
クチルデドシル、コレステロールオレート等のエステル
類を例示することができる。Waxes such as lanolin, carnauba wax, and candelilla wax: liquid paraffin, squalane, microcrystalline wax, ceresin wax, paraffin wax,
Hydrocarbons such as petrolatum; lauric acid, myristic acid,
Natural and synthetic fatty acids such as stearic acid, oleic acid, isostearic acid, behenic acid; Natural and synthetic higher alcohols such as cetanol, stearyl alcohol, hexyldecanol, lauryl alcohol; Isopropyl myristate, isopropyl palmitate, octyldodecyl myristate , octyldedosyl oleate, cholesterol oleate, and other esters.
保湿剤としては、グリセリン、プロピレングリコール、
1.3−ブチレンゲリコール、ソルビトール、ポリエチ
レングリコール、ジプロピレングリコール等の多価アル
コール類;アミノ酸、乳酸ナトリウム、ピロリドンカル
ボン酸ナトリウム等のNMF成分、ヒアルロン酸、コラ
ーゲン、ムコ多糖類。Humectants include glycerin, propylene glycol,
1. Polyhydric alcohols such as 3-butylene gellicol, sorbitol, polyethylene glycol, and dipropylene glycol; amino acids, NMF components such as sodium lactate and sodium pyrrolidone carboxylate, hyaluronic acid, collagen, and mucopolysaccharides.
コンドロイチン硫酸等の水溶性高分子物質等を例示する
ことができる。Examples include water-soluble polymeric substances such as chondroitin sulfate.
増粘剤としては、アルギン酸ナトリウム、キサンタンガ
ム、硅酸アルミニウム、マルメロ種子抽出物、1−ラガ
ントガム、デンプン等の天然高分子物質;メチルセルロ
ース、ヒドロキシエチルセルロース、カルボキシメチル
セルロース、可溶性デンプン、カチオン化セルロース等
の半合成高分子物質;カルボキシビニルポリマー、ポリ
ビニルアルコール等の合成高分子物質等を例示すること
ができる。Thickeners include natural polymeric substances such as sodium alginate, xanthan gum, aluminum silicate, quince seed extract, 1-laganth gum, and starch; semisynthetic substances such as methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, soluble starch, and cationized cellulose. Polymeric substances; synthetic polymeric substances such as carboxyvinyl polymers and polyvinyl alcohol can be exemplified.
防腐剤としては、安息香酸塩、サリチル酸塩、ソルビン
酸塩、デヒドロ酢酸塩、パラオキシ安息香酸エステル、
2,4.4’− トリクロロ−2′−ヒドロキシジフェ
ニルエーテル、3,4.4’−トリクロロカルバニリド
、塩化ベンザルコニウム、ヒノキチオール、レゾルシン
、エタノール等を例示することができる。Preservatives include benzoates, salicylates, sorbates, dehydroacetates, paraoxybenzoic acid esters,
Examples include 2,4,4'-trichloro-2'-hydroxydiphenyl ether, 3,4,4'-trichlorocarbanilide, benzalkonium chloride, hinokitiol, resorcinol, and ethanol.
酸化防止剤としては、ジブチルヒドロキシトルエン、ブ
チルヒドロキシアニソール、没食子酸プロピル、アスコ
ルビン酸等を例示することができる。さらに、キレート
剤としては、エデト酸二ナトリウム、エチレンジアミン
四酢酸塩、ピロリン酸塩、ヘキサメタリン酸塩、クエン
酸、酒石酸、グルコン酸等を、PI(調整剤としては、
水酸化ナトリウム、トリエタノールアミン、クエン酸、
クエン酸ナトリウム、ホウ酸、ホウ砂、リン酸水素カリ
ウム等をそれぞれ例示することができる。Examples of the antioxidant include dibutylhydroxytoluene, butylhydroxyanisole, propyl gallate, ascorbic acid, and the like. Furthermore, as a chelating agent, edetate disodium, ethylenediaminetetraacetate, pyrophosphate, hexametaphosphate, citric acid, tartaric acid, gluconic acid, etc., PI (as a modifier,
Sodium hydroxide, triethanolamine, citric acid,
Examples include sodium citrate, boric acid, borax, and potassium hydrogen phosphate.
紫外線吸収・散乱剤については、2−ヒドロキシ−4−
メトキシベンゾフェノン、オクチルジメチルパラアミノ
ベンゾエート、エチルへキシルパラメトキシサイナメー
ト、酸化チタン、カオリン5タルク等を例示することが
できる。尚、任意成分は、これらに限定されるものでは
ない。上記必須成分と任意成分を適当に配合することに
より、クリーム、乳液、化粧水、パック剤、パウダー、
リップクリーム、口紅、アンダーメークアップ、ファン
デーション、サンケア等種々の製品形態として用いるこ
とが可能である。For ultraviolet absorbing and scattering agents, 2-hydroxy-4-
Examples include methoxybenzophenone, octyl dimethyl para-aminobenzoate, ethylhexyl para-methoxycynamate, titanium oxide, and kaolin 5-talc. Note that the optional components are not limited to these. By appropriately blending the above essential ingredients and optional ingredients, creams, emulsions, lotions, packs, powders,
It can be used in various product forms such as lip balm, lipstick, under makeup, foundation, and sun care.
本発明の化粧料の具体例について示すと、例えば、皮膚
用クリームとしては;必須成分:0.02〜10%、油
分=20〜70%、界面活性剤:2〜7%、保湿剤:5
〜10%、精製水:バランス、防腐剤:微量、香”料:
微量を含有する組成物、乳液としては;必須成分:):
02〜10%。To show specific examples of the cosmetics of the present invention, for example, as a skin cream: Essential ingredients: 0.02 to 10%, Oil content: 20 to 70%, Surfactant: 2 to 7%, Humectant: 5
~10%, Purified water: Balance, Preservative: Trace amount, Fragrance:
As for compositions and emulsions containing trace amounts; essential ingredients:):
02-10%.
油分=10〜40%、界面活性剤=1〜5%、保湿剤=
5〜10%。Oil content = 10-40%, surfactant = 1-5%, humectant =
5-10%.
精製水:バランス、防腐剤:微量、香料:微量を含有す
る組成物、化粧水としては;必須成分:0.02〜10
%、アルコール類:2〜50%、界面活性H1:o、5
〜2%、保湿剤:2〜8%、酸化防止剤:0.01〜0
.05%、キレート剤:0.02〜0.1%、PH調整
剤:0.05〜0.2%、精製水:バランス、防腐剤:
微量、色素:微量、香料:微量を含有する組成物、パッ
ク剤としては;必須成分:0.02〜10%、アルコー
ル類:2〜30%、保湿M:2〜to!g、無機粉体:
0〜20%、造膜剤=10〜20%、防腐剤:微景、香
料:微量を含有する組成物等が挙げられる。Purified water: balance, preservative: trace amount, fragrance: composition containing trace amount, as a lotion; essential ingredients: 0.02-10
%, alcohols: 2-50%, surfactant H1: o, 5
~2%, humectant: 2-8%, antioxidant: 0.01-0
.. 05%, chelating agent: 0.02-0.1%, PH adjuster: 0.05-0.2%, purified water: balance, preservative:
A composition containing trace amounts, pigments: trace amounts, fragrances: trace amounts, as a pack; essential ingredients: 0.02-10%, alcohols: 2-30%, moisturizing M: 2-to! g, inorganic powder:
Examples include compositions containing 0 to 20%, film forming agent = 10 to 20%, preservative: slight amount, and fragrance: trace amount.
本発明によれば、従来品よりも美白効果にすぐれ、しか
も安全性の高い化粧料が提供される。According to the present invention, a cosmetic is provided which has a superior whitening effect and is highly safe than conventional products.
従って、本発明の化粧料は、各種化粧用クリ−ム、乳液
、化粧水、パック剤、パウダー、リップクリーム、口紅
、アンダーメークアップ、ファンデーション、サンケア
等種々の製品形態で、特に皮膚化粧料として好適に使用
できる。Therefore, the cosmetics of the present invention can be used in various product forms such as various cosmetic creams, milky lotions, lotions, packs, powders, lip balms, lipsticks, under makeup, foundations, sun care, etc., and especially as skin cosmetics. It can be used suitably.
次に、本発明を実施例によりさらに詳細に説明する。 Next, the present invention will be explained in more detail with reference to Examples.
実施例1
本発明の化粧料による美白効果を証明するため、C57
ブラツクマウスの背部を用いて、UVB (紫外線)照
射により増加する活性メラノサイトの抑制効果を調べた
。試験方法は下記の通りである。Example 1 In order to prove the whitening effect of the cosmetic of the present invention, C57
Using the backs of black mice, the inhibitory effect on active melanocytes increased by UVB (ultraviolet) irradiation was investigated. The test method is as follows.
(1)検体
検体の成分組成(重量%)は表−1に示した通りである
。(1) Sample The component composition (weight %) of the sample is as shown in Table-1.
(2)活性メラノサイト抑制効果試験
C57ブラツクマウス(各群3匹)の背部を毛刈りし、
ワックスで脱毛した後、1/2MED量のUVB (紫
外線)を1日1回、1週間照射する。検体の塗布は、照
射後に1日1回行った。また、評価時期は試験終了後3
日目に行ない、検体の未塗布の活性メラノサイト数を基
準に抑制率を算出した。尚、活性メラノサイト数の測定
は、2N臭化ナトリウム処理で表皮剥離し、ドーパ染色
後、顕微鏡で数えた。その結果を表−1に示す。(2) Active melanocyte suppression effect test The backs of C57 black mice (3 mice in each group) were shaved,
After hair removal with wax, 1/2 MED amount of UVB (ultraviolet rays) is irradiated once a day for one week. The specimen was applied once a day after irradiation. Also, the evaluation period is 3 days after the end of the exam.
The suppression rate was calculated based on the number of active melanocytes in the unapplied sample. The number of active melanocytes was measured by exfoliating the epidermis with 2N sodium bromide treatment, staining with Dopa, and counting using a microscope. The results are shown in Table-1.
表−1の結果から、コウジ酸成分とアロエ成分の両者を
含有する本発明のものは、コウジ酸成分単独で含むもの
より明らかに活性メラノサイトの抑制効果が改善されて
いることがわかる。From the results in Table 1, it can be seen that the product of the present invention containing both a kojic acid component and an aloe component has a clearly improved suppressive effect on active melanocytes compared to a product containing only a kojic acid component.
実施例2
更に、本発明化粧料の美白効果を証明するため、有色モ
ルモットの背部を用いて脱色効果を調べた。Example 2 Furthermore, in order to prove the whitening effect of the cosmetic composition of the present invention, the bleaching effect was examined using the backs of colored guinea pigs.
試験方法は下記の通りである。The test method is as follows.
(1)検体
表−2に示した美白成分及びエタノールを含み、残部が
精製水からなる化粧水を調製した。(1) A lotion was prepared containing the whitening ingredients shown in Sample Table 2 and ethanol, with the remainder being purified water.
(2)脱色効果試験
有色モルモット(各群3匹)の背部を毛刈りした後、各
化粧水50μ℃を1日1回、週5回の割で約4dの範囲
に3週間塗布し、試験終了4日目の皮膚色を色差計で計
測した。その結果を表−2に示す。(2) Depigmentation effect test After the backs of colored guinea pigs (3 animals in each group) were shaved, each lotion at 50 μC was applied once a day, 5 times a week, over an area of approximately 4 d for 3 weeks, and the test was conducted. On the fourth day after completion, skin color was measured using a color difference meter. The results are shown in Table-2.
表−2の結果から、コウジ酸成分とアロエ成分の両者を
含有する本発明の化粧水は、コウジ酸成分単独で含む化
粧水より脱色効果が優れていることがわかる。From the results in Table 2, it can be seen that the lotion of the present invention containing both a kojic acid component and an aloe component has a better decolorizing effect than a lotion containing only a kojic acid component.
実施例3 本発明の、係る各種化粧料例を次に示す。Example 3 Examples of various cosmetics according to the present invention are shown below.
〈クリーム〉
A:油相部
流動パラフィン(#70) 5.0重量
%スクワラン 15.Onセトステ
アリルアルコール 5.0〃密ロウ
2.0〃モノステアリン酸グリセリン
2.0〃POE(20)ソルビタンモノラウレート2
.0〃プロピルパラベン 0.1〃グリ
チルレチン酸 0.2 lrB:水相
部
コウジ酸 0.5重量〃アロ
エ抽出粉末 ・ 1.O〃水溶性コラー
ゲン 0.2〃メチルパラベン
0.2〃精製水 バラ
ンスC:香料 適量
上記処方物A、Bを70℃でそれぞれ混合溶解した後、
BにAを加え均一に乳化する。更にCを加えて冷却し、
クリームを調製する。<Cream> A: Oil phase liquid paraffin (#70) 5.0% by weight squalane 15. On cetostearyl alcohol 5.0 wax
2.0〃Glyceryl monostearate
2.0〃POE(20) Sorbitan monolaurate 2
.. 0 Propyl paraben 0.1 Glycyrrhetinic acid 0.2 lrB: Aqueous phase Kojic acid 0.5 weight Aloe extract powder 1. O Water-soluble collagen 0.2 Methylparaben
0.2〃Purified water Balance C: Fragrance Appropriate amount After mixing and dissolving the above formulations A and B at 70°C,
Add A to B and emulsify uniformly. Further add C and cool.
Prepare the cream.
〈乳 液〉
A:油相部
流動パラフィン(#70) 10.0重量
%イソプロピルミリステート 2.0重量%グリ
セリンモノステアレート 0.5〃ステアリン酸
2.0〃POE(20)ステアリル
エーテル 0.7〃アラントイン
0.1〃ブチルパラベン 0.1
〃B:水相部
コウジ酸 0.5重量%トリエ
タノールアミン 0.5〃グリセリン
2.0〃カーボポール941
Q、l //エタノール
10.0 //メチルパラベン
0.1〃精製水 バランス
C:香料 適量
上記処方物A、 Bを70℃でそれぞれ混合溶解し、B
にAを加え均一に乳化する。更にCを加えて冷却し、乳
液を調製する。<Milk> A: Oil phase liquid paraffin (#70) 10.0% by weight isopropyl myristate 2.0% by weight glycerin monostearate 0.5 stearic acid
2.0 POE (20) Stearyl ether 0.7 Allantoin
0.1 Butylparaben 0.1
B: Water phase Kojic acid 0.5% by weight Triethanolamine 0.5 Glycerin
2.0 Carbopol 941
Q, l // ethanol
10.0 // Methylparaben
0.1〃Purified water Balance C: Fragrance Mix and dissolve appropriate amounts of the above formulations A and B at 70°C,
Add A to the mixture and emulsify it uniformly. Further, add C and cool to prepare a milky lotion.
〈化粧水〉
A:エチルアルコール相部
エチルアルコール 10.0重量%PO
E(80)硬化ヒマシ油 0.3〃メチルパ
ラベン 0.1重量%香料
適量
B:水相部
コウジ酸 0.1重量2アロ
エ抽出液(10%水溶液) l、Q nヒア
ルロン酸 0.1〃アスコルビン酸
リン酸マグネシウム0.5〃グリセリン
3.0〃精製水 バランス
上記処方物Aを均一に溶解後、これをBの水相部に撹拌
しながら徐々に加え、化粧水を調製する。<Lotion> A: Ethyl alcohol phase Ethyl alcohol 10.0% by weight PO
E (80) Hydrogenated castor oil 0.3 Methylparaben 0.1% by weight Fragrance
Appropriate amount B: Aqueous phase Kojic acid 0.1 weight 2 Aloe extract (10% aqueous solution) l, Q n Hyaluronic acid 0.1 Ascorbic acid Magnesium phosphate 0.5 Glycerin
3.0 Purified water balance After uniformly dissolving the above formulation A, gradually add it to the aqueous phase of B while stirring to prepare a lotion.
〈パック剤〉
A:エチルアルコール相部
エチルアルコール 10.0重量%ポリ
ビニルアルコール 15.OIIプロピレン
グリコール 3.OIIメチルパラベン
Q、l uブチルパラベン
0.05 IT酢酸トコフェロール
0.1 7/B:水相部
コウジ酸ナトリウム 1.0重量%アロエ
抽出粉末 1.Q nピロリドンカ
ルボン酸ナトリウム 1.Q uカルボキシメチルセ
ルロースナトリウム5.0 〃
POE(15)オレイルエーテル 1.0 7F
精製水 バランスC:香 料
適量
上記処方物AとBを混合し、70℃で均一に加温混合し
た。更に冷却しながら処方物Cを加えて、ノ(ツク剤を
調製する。<Pack agent> A: Ethyl alcohol phase: Ethyl alcohol 10.0% by weight polyvinyl alcohol 15. OII propylene glycol 3. OII Methylparaben
Q, l u Butylparaben
0.05 IT tocopherol acetate
0.1 7/B: Aqueous phase Sodium kojate 1.0% by weight Aloe extract powder 1. Q n Sodium pyrrolidone carboxylate 1. Q u Sodium carboxymethyl cellulose 5.0 POE (15) oleyl ether 1.0 7F
Purified water Balance C: Fragrance
Appropriate amounts of the above formulations A and B were mixed and heated and mixed uniformly at 70°C. Add Formulation C with further cooling to prepare a thickener.
Claims (2)
び/又は抽出粉末を含有することを特徴とする美白化粧
料。(1) A whitening cosmetic characterized by containing kojic acid and/or its derivatives and aloe extract and/or extract powder.
の配合量が0.01〜10重量%であり、且つ、アロエ
抽出液及び/又は抽出粉末の配合量が0.01〜15重
量%である特許請求の範囲第(1)項記載の美白化粧料
。(2) In the whitening cosmetic, the amount of kojic acid and/or its derivatives is 0.01 to 10% by weight, and the amount of aloe extract and/or extracted powder is 0.01 to 15% by weight. % of the whitening cosmetic according to claim (1).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62280059A JPH01121205A (en) | 1987-11-04 | 1987-11-04 | Skin beautifying cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62280059A JPH01121205A (en) | 1987-11-04 | 1987-11-04 | Skin beautifying cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01121205A true JPH01121205A (en) | 1989-05-12 |
Family
ID=17619731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62280059A Pending JPH01121205A (en) | 1987-11-04 | 1987-11-04 | Skin beautifying cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01121205A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486624A (en) * | 1994-02-01 | 1996-01-23 | Pacific Corporation | Kojic acid derivative |
JPH0892056A (en) * | 1994-09-22 | 1996-04-09 | Kao Corp | Whitening cosmetic |
US5523421A (en) * | 1993-11-16 | 1996-06-04 | Pacific Corporation | Kojic acid derivatives |
JPH09295927A (en) * | 1996-05-01 | 1997-11-18 | Akira Yagi | Tyrosinase inhibitor |
US6710076B2 (en) | 1994-10-24 | 2004-03-23 | Physician's Choice Of Arizona, Inc. | Hydroxy-kojic acid skin peel |
-
1987
- 1987-11-04 JP JP62280059A patent/JPH01121205A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5523421A (en) * | 1993-11-16 | 1996-06-04 | Pacific Corporation | Kojic acid derivatives |
US5486624A (en) * | 1994-02-01 | 1996-01-23 | Pacific Corporation | Kojic acid derivative |
JPH0892056A (en) * | 1994-09-22 | 1996-04-09 | Kao Corp | Whitening cosmetic |
US6710076B2 (en) | 1994-10-24 | 2004-03-23 | Physician's Choice Of Arizona, Inc. | Hydroxy-kojic acid skin peel |
JPH09295927A (en) * | 1996-05-01 | 1997-11-18 | Akira Yagi | Tyrosinase inhibitor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2886591B2 (en) | Cosmetics | |
WO2002060395A1 (en) | Cosmetics | |
JP2000247866A (en) | Skin agent for external use | |
JPS61152613A (en) | Skin cosmetic | |
CA2365660A1 (en) | Treatment for skin | |
JP3490658B2 (en) | Whitening cosmetics | |
JPH0196109A (en) | Skin-beautifying cosmetic | |
JPH11139951A (en) | Cosmetic | |
JPH01121205A (en) | Skin beautifying cosmetic | |
JP4500906B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
JPH10212225A (en) | Wrinkle preventive | |
JP2002370962A (en) | Bleaching preparation and cosmetic for preventing and improving aging of skin | |
JP2000212057A (en) | Cosmetic composition | |
JP2002128632A (en) | Cosmetic | |
JP2781982B2 (en) | External preparation for skin | |
JPH11292752A (en) | Beautifully whitening agent and composition for external use for skin | |
JPH01121206A (en) | Skin beautifying cosmetic | |
JP2786233B2 (en) | External preparation for skin | |
JPH01121207A (en) | Skin beautifying cosmetic | |
JPH08259420A (en) | Composition for skin external preparation | |
KR100364314B1 (en) | Use of unfermented honey as a depigmenting agent | |
JP2010059115A (en) | Skin care method | |
JPH09202711A (en) | Beautifying and whitening agent and external preparation composition | |
JP2005029577A (en) | Compounding ingredient for cosmetic and cosmetic compounded with the same | |
JP2000351722A (en) | Skin cosmetic |